EGFR TKI

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

November, 2024

EGFR TKI

Aug 26, 2024, 21:24 | Blog

Tanja Obradovic: Can we expect new EGFR TKI to surpass osimertinib in primary tumor and intracranial progression of NSCLC

Tanja Obradovic posted on LinkedIn: “Can we expect new EGFR TKI that can significantly surpass…

Aug 6, 2024, 01:06 | Insight

Metastatic lung adenocarcinoma with EGFR and TP53 co-mutations shows mixed intra-patient tumor responses

Yüksel Ürün shared on X: "Metastatic lung adenocarcinoma with Epidermal Growth Factor Receptor (EGFR) and…

May 29, 2024, 09:22 | Blog

Eric K. Singhi: Isn’t it about time we stopped saying that "patients failed treatment"

Eric K. Singhi reshared his previous post on X and added: ; "But…

Feb 5, 2024, 11:27 | Insight

Stephen V Liu: The optimal strategy for unresectable stage III NSCLC after chemoradiation in EGFR mutant NSCLC

Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Lombardi Comprehensive Cancer Center,…

All: 4 Posts: 1 - 100

Dr. Richard Pazdur's 25 Year WAR on Cancer at the FDA!

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Donald Trump: Thrilled to announce Robert F. Kennedy Jr. as The United States Secretary of HHS

Overview of ASCO Breakthrough

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023